日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01

达托泊单抗德鲁替康对比化疗治疗既往接受过治疗的不可手术/转移性激素受体阳性、人表皮生长因子受体2阴性乳腺癌:TROPION-Breast01研究的主要结果

Bardia, Aditya; Jhaveri, Komal; Im, Seock-Ah; Pernas, Sonia; De Laurentiis, Michelino; Wang, Shusen; Martínez Jañez, Noelia; Borges, Giuliano; Cescon, David W; Hattori, Masaya; Lu, Yen-Shen; Hamilton, Erika; Zhang, Qingyuan; Tsurutani, Junji; Kalinsky, Kevin; Rubini Liedke, Pedro Emanuel; Xu, Lu; Fairhurst, Rick M; Khan, Sabrina; Denduluri, Neelima; Rugo, Hope S; Xu, Binghe; Pistilli, Barbara

Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial

在绝经后内分泌敏感型激素受体阳性、HER2阴性晚期乳腺癌女性患者中,帕博西尼联合氟维司群与安慰剂联合氟维司群治疗的生活质量比较:FLIPPER试验的患者报告结局

Tibau, Ariadna; Martínez, M Teresa; Ramos, Manuel; De La Cruz-Merino, Luis; Santaballa, Ana; O'Connor, Miriam; Martínez-Jañez, Noelia; Moreno, Fernando; Fernández, Isaura; Virizuela, Juan Antonio; Alarcón, Jesús; de La Haba-Rodríguez, Juan; Sánchez-Rovira, Pedro; Albacar, Cinta Rosa; Bueno Muiño, Coralia; Kelly, Catherine; Casas, Maribel; Bezares, Susana; Rosell, Libertad; Albanell, Joan

Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer

MNK1b(MNK1 的剪接异构体)表达增加预示预后不良,且与三阴性乳腺癌相关

Celia Pinto-Díez, Eva M García-Recio, M Isabel Pérez-Morgado, Marta García-Hernández, Lara Sanz-Criado, Silvia Sacristán, M Val Toledo-Lobo, Belén Pérez-Mies, Isabel Esteban-Rodríguez, Alejandro Pascual, Mercedes Garcia-Villanueva, Noelia Martínez-Jañez, Víctor M González, M Elena Martín

Anti-HER2 Therapy Beyond Second-Line for HER2-Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel

HER2阳性转移性乳腺癌二线治疗后的抗HER2疗法:西班牙专家组针对几种临床情景的简要回顾和建议

Martínez-Jañez, Noelia; Chacón, Ignacio; de Juan, Ana; Cruz-Merino, Luis; Del Barco, Sònia; Fernández, Isaura; García-Teijido, Paula; Gómez-Bernal, Amalia; Plazaola, Arrate; Ponce, José; Servitja, Sonia; Zamora, Pilar

Use of bevacizumab as a first-line treatment for metastatic breast cancer

贝伐珠单抗作为转移性乳腺癌的一线治疗

Manso, L; Moreno, F; Márquez, R; Castelo, B; Arcediano, A; Arroyo, M; Ballesteros, A I; Calvo, I; Echarri, M J; Enrech, S; Gómez, A; González Del Val, R; López-Miranda, E; Martín-Angulo, M; Martínez-Jañez, N; Olier, C; Zamora, P